Inger‐Marie Dahl

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.

Stig Lenhoff, Martin Hjorth, Erik Holmberg et al. · PubMed · 2000 · 312 citations

Medicine, Hematology, Oncology +15

A Combination of Granulocvte Colonv-Stimulating Factor and Erythiopoietin may Synergistically Improve the Anaemia in Patients with Myelodysplastic Syndromes

Eva Hellström-Lindberg, Gunnar Birgegård, Magnus Carlsson et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1993 · 83 citations

Medicine, Hematology, Pharmacotherapy +15

Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.

P A Broliden, Inger‐Marie Dahl, Robert Hast et al. · PubMed · 2006 · 71 citations

Medicine, Hematology, Pharmacotherapy +17

Treatment of myelodysplastic syndromes with retinoic acid and 1α‐hydroxy‐vitamin D3 in combination with low‐dose ara‐C is not superior to ara‐C alone. Results from a randomized study

Eva Hellström, Karl‐Henrik Robèrt, Jan Samuelsson et al. · European Journal Of Haematology · 1990 · 50 citations

Medicine, Pharmacology, Pharmacotherapy +12

Improved progression free survival with bortezomib consolidation after high dose melphalan: results of a randomised phase III trial

U. H. Mellquist, Peter Gimsing, Øyvind Hjertner et al. · University of Southern Denmark Research Portal (University of Southern Denmark) · 2011 · 18 citations

Medicine, Oncology, Pharmacology +14